reports
- GlobalData Healthcare Department
Celyad SA (CYAD) - Medical Equipment - Deals and Alliances Profile
Summary Celyad SA (Celyad), formerly Cardio3 BioSciences is a clinical-stage biopharmaceutical company that focuses on the discovery and development of engineered cell therapies. The company offers C-Cure, a cell-based reparative therapy to treat heart failure. It offers C-Cathez, an intraventricular injection catheter used in cardiac surgery operations. Celyad offers NKR-2 and autologous chimeric antigen receptor; among others. The company's heart access technology is used for the treatment of...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.